GlassScriptPhysician profile
Kentson Lam
NPI 1417311325
$4,634.65
in general payments reported to CMS, 2019-2025
7 companies · $3,080 in 2025
The $3,080 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $211 · 2022: $234 · 2023: $518 · 2024: $212 · 2025: $3,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,080 · Food and Beverage: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,080.00 |
| Food and Beverage | $730.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $3,291.94 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $270.81 | 2023 | Opdivo |
| Astrazeneca Pharmaceuticals LP | $264.37 | 2019 | |
| Foundation Medicine, INC. | $247.49 | 2023 | |
| Merck Sharp & Dohme LLC | $237.41 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $213.20 | 2019-2020 | |
| Rigel Pharmaceuticals, INC. | $109.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kentson Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.